Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on DAR. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-step iridium-catalyzed method for fluorine-containing secondary amines using stable fluorinated alcohols, offering significant cost and safety advantages for pharmaceutical manufacturing.
Novel two-step synthesis for Amiodarone intermediate improves yield and reduces cost. Reliable supply chain solution for pharmaceutical manufacturing.
Advanced synthesis of 5-[(2R)-2-aminopropyl]-1-[3-(benzoyloxy)propyl]-7-cyano-1H-indole salt via oxidative dehydrogenation for superior pharmaceutical quality control and supply reliability.
Novel boron-catalyzed hydroamination method offers high yield and mild conditions for pharmaceutical intermediates manufacturing ensuring supply chain reliability.
Patent CN116283937B reveals metal-free photocatalytic synthesis for high-purity aromatic secondary amines, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN103588709B reveals solvent-free Edaravone synthesis. High purity >98% yields ensure cost reduction in API manufacturing and supply chain stability.
Patent CN101314559B details a low-cost kinetic resolution method for aromatic chiral secondary alcohols using Boc-Proline, offering high purity for pharma intermediates.
Advanced total synthesis of 13C7-patulin via patent CN113004300A. High purity isotope standards for precise mass spectrometry quantification in agrochemical and food testing.
Patent CN115894387A reveals a novel oxidation route for prothioconazole metabolites. Achieve 99% purity with scalable, cost-effective synthesis for residue analysis.
Patent CN102731386B reveals a novel Pd-catalyzed route for secondary diimides, offering neutral conditions and cost reduction in API manufacturing for global supply chains.
Patent CN112675920B reveals a novel Ruthenium catalyst for efficient chiral alcohol synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable production methods.
Novel one-pot Suzuki coupling method for Darolutamide intermediate. Eliminates column chromatography, reduces cost, ensures supply continuity for pharmaceutical manufacturing.
Novel synthesis of Danshensu Isopropyl Ester via Darzens epoxidation ensures high purity and yield. Reliable supply chain partner for cardiovascular drug intermediates.
Patent CN107628964B enables mild carbonylation for high-purity API intermediates. Reduces cost in fine chemical manufacturing with scalable Pd-catalyzed routes.
Novel Darzens condensation method for lycopene intermediate ensures high purity and cost efficiency. Reliable supply chain solution for pharmaceutical manufacturing.
Patent CN100389877C details a novel PEG-supported ruthenium catalyst enabling ambient pressure asymmetric hydrogenation, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN107382741B details a high-yield B(C6F5)3 catalyzed hydroamination. Offers cost-effective, scalable routes for pharmaceutical intermediates with minimal impurities.
Efficient carbonylation method for N-aryl amides using aryl boronic acids. Reduces harsh conditions, offering cost-effective manufacturing for pharmaceutical intermediates.
Novel patent CN115703691B details safer synthesis for isotope standards. Reduces toxicity and cost for pharma intermediate supply chains.
Discover a novel, catalyst-free synthesis of N-nitrosamines using sulfonyl fluoride. Enhance purity and reduce costs in pharmaceutical intermediate manufacturing with this green technology.